Liraglutide · 1 matching version
NCT03158805
Matching submitted history spans March 3, 2025 to March 3, 2025.
Open complete source-attributed timeline →Source-declared changed module
Limitations and Caveats history
25 public ClinicalTrials.gov history versions across 23 trial records where the source marks Limitations and Caveats as changed. The label does not identify the changed fields, meaning, reason, or materiality.
Exenatide · 1 matching version
NCT02157974
Matching submitted history spans May 31, 2024 to May 31, 2024.
Open complete source-attributed timeline →Liraglutide · 1 matching version
NCT03036800
Matching submitted history spans March 4, 2024 to March 4, 2024.
Open complete source-attributed timeline →Tesamorelin · 1 matching version
NCT00608023
Matching submitted history spans September 16, 2022 to September 16, 2022.
Open complete source-attributed timeline →Leuprolide · 1 matching version
NCT02278185
Matching submitted history spans April 26, 2022 to April 26, 2022.
Open complete source-attributed timeline →Teriparatide · 2 matching versions
NCT02023411
Matching submitted history spans August 25, 2020 to June 28, 2021.
Open complete source-attributed timeline →Lanreotide · 1 matching version
NCT03012594
Matching submitted history spans December 23, 2020 to December 23, 2020.
Open complete source-attributed timeline →Octreotide · 1 matching version
NCT02916433
Matching submitted history spans August 27, 2020 to August 27, 2020.
Open complete source-attributed timeline →Elamipretide · 2 matching versions
NCT02788747
Matching submitted history spans April 6, 2020 to May 5, 2020.
Open complete source-attributed timeline →Leuprolide · 1 matching version
NCT00687739
Matching submitted history spans November 20, 2019 to November 20, 2019.
Open complete source-attributed timeline →Exenatide · 1 matching version
NCT02104739
Matching submitted history spans June 1, 2018 to June 1, 2018.
Open complete source-attributed timeline →Glucagon · 1 matching version
NCT01680653
Matching submitted history spans January 30, 2018 to January 30, 2018.
Open complete source-attributed timeline →Tesamorelin · 1 matching version
NCT01263717
Matching submitted history spans September 28, 2017 to September 28, 2017.
Open complete source-attributed timeline →Teriparatide · 1 matching version
NCT01153425
Matching submitted history spans August 1, 2017 to August 1, 2017.
Open complete source-attributed timeline →Exenatide · 1 matching version
NCT01588418
Matching submitted history spans April 17, 2017 to April 17, 2017.
Open complete source-attributed timeline →Lanreotide · 1 matching version
NCT00774930
Matching submitted history spans December 28, 2016 to December 28, 2016.
Open complete source-attributed timeline →Exenatide · 1 matching version
NCT01444898
Matching submitted history spans September 27, 2016 to September 27, 2016.
Open complete source-attributed timeline →Exenatide · 1 matching version
NCT00650546
Matching submitted history spans April 7, 2016 to April 7, 2016.
Open complete source-attributed timeline →Teriparatide · 1 matching version
NCT00473265
Matching submitted history spans July 14, 2015 to July 14, 2015.
Open complete source-attributed timeline →Exenatide · 1 matching version
NCT00546728
Matching submitted history spans September 5, 2013 to September 5, 2013.
Open complete source-attributed timeline →Teriparatide · 1 matching version
NCT00826228
Matching submitted history spans June 3, 2013 to June 3, 2013.
Open complete source-attributed timeline →Leuprolide · 1 matching version
NCT00004635
Matching submitted history spans August 13, 2012 to August 13, 2012.
Open complete source-attributed timeline →Teriparatide · 1 matching version
NCT00439244
Matching submitted history spans March 23, 2011 to March 23, 2011.
Open complete source-attributed timeline →